Liverpool Ocular Oncology<br />Research Group
  • HOME
  • RESEARCH STUDY
  • News
  • LOORG Members
  • Alumni
    • Previous Staff
    • Past PhD Students
    • Past MD Students
    • Past MRes Students
    • Past BSc/MSc Students
  • Visitors
    • Visiting researchers and clinicians
    • Visiting Students
  • Collaborators
    • Links
  • Clinical
    • MLPA
    • MSA
    • GNAQ/GNA11
    • BRAF
  • Patient area
    • Disease focus
    • Our research
    • Our projects >
      • ITEM
      • SUAVE
      • NITRO
      • The role of tumour stem cells in uveal melanoma development
      • Identification of regulators of metastasis
      • Molecular characteristics of metastatic liver lesions in uveal melanoma
      • Proteomic discovery of serum biomarkers in metastatic UM
      • The role of a novel inhibitory isoform of VEGF in ocular melanoma
      • Gross chromosomal abnormalities in iris melanoma
      • Conjunctival melanoma: a multicentre study correlating baseline features with histology and genetics
      • Estimating survival prognosis after treatment of choroidal melanoma
    • Further information
    • Glossary >
      • A - D
      • E - H
      • I - N
      • O - S
      • T - Z
  • Ocular Oncology Biobank (OOB)
  • Publications
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • Athena SWAN initiative
  • Support Us/Donations
  • Fundraising Events
  • Training and Opportunities
  • Contact us
  • Just Giving Instructions
Picture
Back
Picture

The role of a novel inhibitory isoform of VEGF in ocular melanoma

Prof. Sarah Coupland
Prof. Bertil Damato
Dr Helen Kalirai
Dr Sarah Lake
Mr Andrew Dodson
Dr Martina Angi

Collaborators:

Dr Rowan Pritchard-Jones
Dr Maxine Emmett
 
Summary


The growth of new blood vessels from existing ones is known as angiogenesis. It is this process that is not only essential for cancer cell survival and growth of the tumour, but it also helps the cancer cells move into the bloodstream and spread to distant organs. Vascular Endothelial Growth Factor (VEGF) is known to be the most potent stimulator of blood vessel formation, however, recent studies have shown that different forms of this factor exist that can also prevent blood vessel formation. The aim of this study is to understand how these different forms of the VEGF may be involved in the growth and spread of uveal melanoma cells.

Funded by:

Picture
Powered by Create your own unique website with customizable templates.